The coronavirus pandemic has swept through the world, leaving healthcare systems high and dry. Apart from that, economies are stranded, millions have lost their jobs, and of course, so many more are battling for their lives against the disease. As scientists across the world continue to search for an answer against the dreaded COVID-19, a ray of hope still sustains, hinting that this will be over. It’s only a question of when.
However, even if the restrictions and lockdowns are lifted slowly as the situation starts coming in control, getting back to normalcy is far-sighted. At least, that is what USA Health CMO Dr. Michael Chang suggests. He opined that, till the time a vaccine is not created, we will keep dealing with the virus.
Dr. Chang commented, “We’ve already seen that there are some patients that have been putting off procedures that really just need to be done and have moved from being what I would call non-time sensitive to becoming time-sensitive. Those need to be done for the betterment of the patient’s health because it’s much better to do a preventive procedure than it is to try and salvage a patient in an emergency.”
Also Read: Injecting Disinfectant Can Treat Coronavirus – Donald Trump
The USA Health CMO went on to add that the pandemic has completely changed the way healthcare is approached and delivered, and it will continue to do so until a working vaccine is created.
As far as the treatment process of non-COVID patients is concerned, elective surgeries will be on hold until the Alabama Department of Public Health deems it as safe. USA Health has announced that any general patient requiring operation under the elective category, that requires the use of a ‘breathing tube or something similar’, will first be tested for COVID-19.
Dr. Chang argued that a lot of patients who can be treated are voluntarily stepping aside from the procedures, in fear of the virus. He also assured that the healthcare system is capable of handling general cases even amid the pandemic, and is adopting all safety precautions.